Justin Chakma, Chief Business Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 90,000 shares at $13.19 ($1.2M) on 2024-12-03, disclosed to the SEC on 2024-12-04.
Open-market sale of $1.2M SPRY by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.67 | 45,000 | $615K | 50.9% |
| 2 | $13.19 | 45,000 | $594K | 49.1% |
| Total | $13.43 avg | 90,000 | $1.2M | 100% |
| Filing → |
| SPRY | SELL | 2024-12-12 | $658K | — | Filing → |
| SPRY | SELL | 2024-12-06 | $2.7M | — | Filing → |
| SPRY | SELL | 2024-11-27 | $2.0M | — | Filing → |